NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

CUSIP: 641288105

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33,235,472
Total 13F shares
14,795,861
Share change
+225,626
Total reported value
$103,125,040
Put/Call ratio
7.7%
Price per share
$6.97
Number of holders
48
Value change
+$1,471,249
Number of buys
21
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 641288105?
CUSIP 641288105 identifies NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q3 2024

As of 30 Sep 2024, NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,795,861 shares. The largest 10 holders included ORBIMED ADVISORS LLC, MORGAN STANLEY, Soleus Capital Management, L.P., Kent Lake PR LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., Nantahala Capital Management, LLC, ARMISTICE CAPITAL, LLC, and DEUTSCHE BANK AG\. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.